| Product Code: ETC9562271 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Personalized Cancer Medicine Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Personalized Cancer Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Personalized Cancer Medicine Market - Industry Life Cycle |
3.4 Sweden Personalized Cancer Medicine Market - Porter's Five Forces |
3.5 Sweden Personalized Cancer Medicine Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Sweden Personalized Cancer Medicine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Personalized Cancer Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Sweden |
4.2.2 Technological advancements in personalized medicine |
4.2.3 Growing awareness and acceptance of personalized cancer treatments |
4.2.4 Supportive government policies and investments in healthcare |
4.2.5 Rising demand for targeted therapies |
4.3 Market Restraints |
4.3.1 High costs associated with personalized cancer medicine |
4.3.2 Regulatory challenges and approval processes |
4.3.3 Limited infrastructure and expertise for personalized medicine |
4.3.4 Ethical considerations and patient data privacy concerns |
4.3.5 Resistance from traditional healthcare systems |
5 Sweden Personalized Cancer Medicine Market Trends |
6 Sweden Personalized Cancer Medicine Market, By Types |
6.1 Sweden Personalized Cancer Medicine Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Sweden Personalized Cancer Medicine Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Sweden Personalized Cancer Medicine Market Revenues & Volume, By Personalized Medicine Diagnostics, 2021- 2031F |
6.1.4 Sweden Personalized Cancer Medicine Market Revenues & Volume, By Personalized Medicine Therapeutics, 2021- 2031F |
6.2 Sweden Personalized Cancer Medicine Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Sweden Personalized Cancer Medicine Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.2.3 Sweden Personalized Cancer Medicine Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Personalized Cancer Medicine Market Import-Export Trade Statistics |
7.1 Sweden Personalized Cancer Medicine Market Export to Major Countries |
7.2 Sweden Personalized Cancer Medicine Market Imports from Major Countries |
8 Sweden Personalized Cancer Medicine Market Key Performance Indicators |
8.1 Patient response rates to personalized cancer treatments |
8.2 Adoption rates of personalized medicine technologies in oncology clinics |
8.3 Research and development investments in personalized cancer medicine |
8.4 Number of clinical trials focused on personalized cancer therapies |
8.5 Patient satisfaction and quality of life improvements with personalized treatments |
9 Sweden Personalized Cancer Medicine Market - Opportunity Assessment |
9.1 Sweden Personalized Cancer Medicine Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Sweden Personalized Cancer Medicine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Personalized Cancer Medicine Market - Competitive Landscape |
10.1 Sweden Personalized Cancer Medicine Market Revenue Share, By Companies, 2024 |
10.2 Sweden Personalized Cancer Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here